The Genomic Relationship Between Primary Breast Carcinomas and Their Nodal Metastases

REFERENCES

• Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003;3:55–63.
   PubMed Web of Science ®Google Scholar
• Vaidya KS, Welch DR. Metastasis suppressors and their roles in breast carcinoma. J Mammary Gland Biol Neoplasia 2007;12:175–190.
   PubMed Web of Science ®Google Scholar
• Desouki MM, Liao S, Huang H, Conroy J, Nowak NJ, Shepherd L, Gaile DP, Geradts J. Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach. J Cancer Res Clin Oncol 2010 (Epub ahead of print).
   PubMedGoogle Scholar
• Cowell JK, Wang YD, Head K, Conroy J, McQuaid D, Nowak NJ. Identification and characterisation of constitutional chromosome abnormalities using arrays of bacterial artifacial chromosomes. Br J Cancer 2004;90:860–865.
   PubMed Web of Science ®Google Scholar
• Kuukasjärvi T, Karhu R, Tanner, M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997;57:1597–1604.
   PubMed Web of Science ®Google Scholar
• Torres L, Ribeiro FR, Pandis N, Andersen JA, Heim S, Teixeira MR. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Breast Cancer Res Treat 2007;102:143–155.
   PubMed Web of Science ®Google Scholar
• Wang C, Iakovlev VV, Wong V, Leung S, Warren K, Iakovleva G, Arneson NCR, Pintilie M, Miller N, Youngson B, McCready DR, Done SJ. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study. Genes Chromosomes Cancer 2009;48:1091–1101.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci U S A 2003;100:15901–15905.
   PubMed Web of Science ®Google Scholar
• Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, Ning L, Fang Z, Wang Y, Zhang L, Cheng J, Zhang W, Hao X. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res Treat 2007;103:319–329.
   PubMed Web of Science ®Google Scholar
• Vecchi M, Confalonieri S, Nuciforo P, Viganò MA, Capra M, Bianchi M, Nicosia D, Bianchi F, Galimberti V, Viale G, Palermo G, Riccardi A, Campanini R, Daidone MG, Pierotti MA, Pece S, DiFiore PP. Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene 2008;27:2148–2158.
   Google Scholar
• Nishizaki T, DeVries S, Chew K, Goodson WH, Ljung BM, Thor A, Waldman FM. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 1997;19:267–272.
   PubMed Web of Science ®Google Scholar
• Ellsworth RE, Ellsworth DL, Neatrour DM, Deyarmin B, Lubert SM, Sarachine MJ, Brown P, Hooke JA, Shriver CD. Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes. Mol Cancer Res 2005;3:71–77.
   PubMed Web of Science ®Google Scholar
• Mohsin SK, Weiss H, Havighurst T, Clark GM, Berardo M, Roanh LD, To TV, Qian Z, Love RR, Allred DC. Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol 2004;17:1545–1554.
   PubMed Web of Science ®Google Scholar
• Hong H, Yang L, Stallcup MR. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J Biol Chem 1999;274:22618–22626.
   PubMed Web of Science ®Google Scholar
• Gao M, Sun P, Wang J, Zhao D, Wei L. Expression of estrogen receptor-related receptor isoforms and clinical significance in endometrial adenocarcinoma. Int J Gynecol Cancer 2006;16:827–833.
   PubMed Web of Science ®Google Scholar
• Ariazi EA, Clark GM, Mertz JE. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 2002;62:6510–6518.
   PubMed Web of Science ®Google Scholar
• Seto M, Yamamoto K, Takahashi T, Ueda R. Cloning and expression of a murine cDNA homologous to the human RCK/P54, a lymphoma-linked chromosomal translocation junction gene on 11q23. Gene 1995;166:293–296.
   PubMed Web of Science ®Google Scholar
• Lin F, Wang R, Shen JJ, Wang X, Gao P, Dong K, Zhang HZ. Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo. Cancer Biol Ther 2008;7:1669–1676.
   PubMed Web of Science ®Google Scholar
• Lambert JM, Lambert QT, Reuther GW, Malliri A, Siderovski DP, Sondek J, Collard JG, Der CJ. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism. Nat Cell Biol 2002;8:621–625.
   Google Scholar
• Liu L, Wu DH, Ding YQ. Tiam1 gene expression and its significance in colorectal carcinoma. World J Gastroenterol 2005;11: 705–707.
   PubMed Web of Science ®Google Scholar
• Zhang XM, Jin H, Chen JZ, Yu LN, Li YF. Relationship between Tiam-1 expression and the biological behaviors of nasopharyngeal carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 2009;29:26–28.
   PubMedGoogle Scholar
• Engers R, Mueller M, Walter A, Collard JG, Willers R, Gabbert. H.E. Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer 2006;95:1081–1086.
   PubMed Web of Science ®Google Scholar
• Moriarty CH, Pursell B, Mercurio AM. miR-10b targets Tiam1: implications for Rac activation and carcinoma migration. J Biol Chem 2010;285:20541–20546.
   PubMed Web of Science ®Google Scholar
• Adams HC, Chen R, Liu Z, Whitehead IP. Regulation of breast cancer cell motility by T-cell lymphoma invasion and metastasis-inducing protein. Breast Cancer Res 2010;12:R69 (Epub ahead of print).
   Google Scholar
• Sivaram MV, Wadzinski TL, Redick SD, Manna T, Doxsey SJ. Dynein light intermediate chain 1 is required for progress through the spindle assembly checkpoint. EMBO J 2009;28:902–914.
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Bagheri-Yarmand R, Yang Z, Balasenthil S, Nguyen. D, Sahin AA, den Hollander P, Kumar R. Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes. Cancer Cell 2004;6:575– 585.
   Google Scholar
• Xu J, Sankaran VG, Ni M, Menne TF, Menne TF, Puram RV, Kim W, Orkin SH. Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev 2010;24:783–798.
   PubMed Web of Science ®Google Scholar
• Ueda R, Yoshida K, Kawakami Y, Kawase T, Toda M. Expression of a transcriptional factor, SOX6, in human gliomas. Brain Tumor Pathol 2004;21:35–38.
   PubMedGoogle Scholar
• Ke N, Godzik A, Reed, JC. Bcl-B: a novel Bcl-2 family member that differentially binds and regulates Bax and Bak. J Biol Chem 2001;276:12481–12484.
   PubMed Web of Science ®Google Scholar
• Zhang H, Holzgreve W, DeGeyter C. Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway. Hum Mol Genet 2001;10:2329–2339.
   PubMed Web of Science ®Google Scholar
• Krajewska M, Kitada S, Winter JN, Variakojis D, Lichtenstein A, Zhai D, Cuddy M, Huang X, Luciano F, Baker CH, Kim H, Shin E, Kennedy S, Olson AH, Badzio A, Jassem J, Meinhold-Heerlein I, Duffy MJ, Schimmer AD, Tsao M, Brown E, Sawyers A, Andreeff M, Mercola D, Krajewski S, Reed JC. Bcl-B expression in human epithelial and nonepithelial malignancies. Clin Cancer Res 2008;14:3011–3021.
   Google Scholar
• Lahusen T, Henke RT, Kagan BL, Wellstein A, Riegel AT. The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer. Breast Cancer Res Treat 2009;116:225– 237.
   PubMed Web of Science ®Google Scholar
• Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang SI, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, Cloutier T, Kuo WL, Yaswen P, Dairkee S, Giovanola J, Hutchinson GB, Isola J, Kallioniemi OP, Palazzolo M, Martin C, Ericsson C, Pinkel D, Albertson D, Li WB, Gray JW. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A 1998;95:8703–8708.
   Google Scholar
• Li HC, Cao DC, Liu Y, Hou YF, Wu J, Lu JS, Di GH, Liu G, Li FM, Ou ZL, Jie C, Shen ZZ, Shao ZM. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Res Treat 2004;88:75–85.
   PubMed Web of Science ®Google Scholar
• Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I, Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R, Cheng SY. ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res 2007;67:7203–7211.
   PubMed Web of Science ®Google Scholar
• Wurdak H, Zhu S, Romero A, Lorger M, Watson J, Chiang CY, Zhang J, Natu VS, Lairson LL, Walker JR, Trussell CM, Harsh GR, Vogel H, Felding-Habermann B, Orth AP, Miraglia LJ, Rines DR, Skirboll SL, Schultz PG. An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. Cell Stem Cell 2010;6:37–47.
   PubMedGoogle Scholar
• Sauve F, McBroom LD, Gallant J, Moraitis AN, Labrie F, Giguere V. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant. Mol Cell Biol 2001;21:343–353.
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M. Human FOX gene family. Int J Oncol 2004;25:1495–1500.
   PubMed Web of Science ®Google Scholar